Mechanisms of lung ischemia-reperfusion injury
Top Cited Papers
- 1 June 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Organ Transplantation
- Vol. 21 (3), 246-252
- https://doi.org/10.1097/mot.0000000000000304
Abstract
Lungs are extremely susceptible to injury, and despite advances in surgical management and immunosuppression, outcomes for lung transplantation are the worst of any solid organ transplant. The success of lung transplantation is limited by high rates of primary graft dysfunction because of ischemia-reperfusion injury characterized by robust inflammation, alveolar damage, and vascular permeability. This review will summarize major mechanisms of lung ischemia-reperfusion injury with a focus on the most recent findings in this area. Over the past 18 months, numerous studies have described strategies to limit lung ischemia-reperfusion injury in experimental settings, which often reveal mechanistic insight. Many of these strategies involved the use of various antioxidants, anti-inflammatory agents, mesenchymal stem cells, and ventilation with gaseous molecules. Further advancements have been achieved in understanding mechanisms of innate immune cell activation, neutrophil infiltration, endothelial barrier dysfunction, and oxidative stress responses. Methods for prevention of primary graft dysfunction after lung transplant are urgently needed, and understanding mechanisms of ischemia-reperfusion injury is critical for the development of novel and effective therapeutic approaches. In doing so, both acute and chronic outcomes of lung transplant recipients will be significantly improved.Keywords
This publication has 53 references indexed in Scilit:
- NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia–Reperfusion InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Annexin V homodimer protects against ischemia reperfusion–induced acute lung injury in lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2016
- Inflation with carbon monoxide in rat donor lung during cold ischemia phase ameliorates graft injuryExperimental Biology and Medicine, 2015
- Bone marrow‐derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion‐induced lung injuryJournal of Cellular and Molecular Medicine, 2015
- Role of Toll-Like Receptor-4 in Lung Ischemia-Reperfusion InjuryThe Annals of Thoracic Surgery, 2015
- Differential toll-like receptor activation in lung ischemia reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2015
- Neutrophil Extracellular Traps Are Pathogenic in Primary Graft Dysfunction after Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Infusion of Mesenchymal Stem Cells Protects Lung Transplants from Cold Ischemia-Reperfusion Injury in MiceLung, 2014
- Hypoxia-inducible factor 1 alpha contributes to pulmonary vascular dysfunction in lung ischemia-reperfusion injury.2014
- Apyrase treatment prevents ischemia–reperfusion injury in rat lung isograftsThe Journal of Thoracic and Cardiovascular Surgery, 2009